BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 16024109)

  • 21. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials.
    Dibbs Z; Thornby J; White BG; Mann DL
    J Am Coll Cardiol; 1999 Jun; 33(7):1935-42. PubMed ID: 10362196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
    Nowak J; Rozentryt P; Szewczyk M; Gierlotka M; Duszańska A; Szyguła B; Wojnicz R; Hawranek M; Poloński L; Zembala M
    Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise.
    Febbraio MA; Steensberg A; Starkie RL; McConell GK; Kingwell BA
    Metabolism; 2003 Jul; 52(7):939-44. PubMed ID: 12870175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size.
    Mikkelsen UR; Couppé C; Karlsen A; Grosset JF; Schjerling P; Mackey AL; Klausen HH; Magnusson SP; Kjær M
    Mech Ageing Dev; 2013; 134(11-12):531-40. PubMed ID: 24287006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
    Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT
    Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cytokine parameters and mortality in patients with chronic heart failure.
    Rauchhaus M; Doehner W; Francis DP; Davos C; Kemp M; Liebenthal C; Niebauer J; Hooper J; Volk HD; Coats AJ; Anker SD
    Circulation; 2000 Dec; 102(25):3060-7. PubMed ID: 11120695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure.
    Lommi J; Pulkki K; Koskinen P; Näveri H; Leinonen H; Härkönen M; Kupari M
    Eur Heart J; 1997 Oct; 18(10):1620-5. PubMed ID: 9347273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation.
    Niebauer J; Pflaum CD; Clark AL; Strasburger CJ; Hooper J; Poole-Wilson PA; Coats AJ; Anker SD
    J Am Coll Cardiol; 1998 Aug; 32(2):393-7. PubMed ID: 9708466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response to inspiratory muscle training in patients with chronic heart failure.
    Laoutaris ID; Dritsas A; Brown MD; Manginas A; Kallistratos MS; Degiannis D; Chaidaroglou A; Panagiotakos DB; Alivizatos PA; Cokkinos DV
    Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):679-85. PubMed ID: 17925628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
    Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
    Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between isokinetic muscle strength and exercise capacity in chronic heart failure.
    Clark A; Rafferty D; Arbuthnott K
    Int J Cardiol; 1997 Apr; 59(2):145-8. PubMed ID: 9158166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats.
    Cunha TF; Bechara LR; Bacurau AV; Jannig PR; Voltarelli VA; Dourado PM; Vasconcelos AR; Scavone C; Ferreira JC; Brum PC
    J Appl Physiol (1985); 2017 Apr; 122(4):817-827. PubMed ID: 28104751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
    Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
    Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Aukrust P; Ueland T; Lien E; Bendtzen K; Müller F; Andreassen AK; Nordøy I; Aass H; Espevik T; Simonsen S; Frøland SS; Gullestad L
    Am J Cardiol; 1999 Feb; 83(3):376-82. PubMed ID: 10072227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure.
    Massie BM; Simonini A; Sahgal P; Wells L; Dudley GA
    J Am Coll Cardiol; 1996 Jan; 27(1):140-5. PubMed ID: 8522687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary fat intake and proinflammatory cytokine levels in patients with heart failure.
    Lennie TA; Chung ML; Habash DL; Moser DK
    J Card Fail; 2005 Oct; 11(8):613-8. PubMed ID: 16230265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.
    Rauchhaus M; Koloczek V; Volk H; Kemp M; Niebauer J; Francis DP; Coats AJ; Anker SD
    Int J Cardiol; 2000; 76(2-3):125-33. PubMed ID: 11104867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
    Schols AM; Buurman WA; Staal van den Brekel AJ; Dentener MA; Wouters EF
    Thorax; 1996 Aug; 51(8):819-24. PubMed ID: 8795671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.